CN102018760A - Traditional Chinese medicine for treating benign prostatic hyperplasia - Google Patents
Traditional Chinese medicine for treating benign prostatic hyperplasia Download PDFInfo
- Publication number
- CN102018760A CN102018760A CN2010102321507A CN201010232150A CN102018760A CN 102018760 A CN102018760 A CN 102018760A CN 2010102321507 A CN2010102321507 A CN 2010102321507A CN 201010232150 A CN201010232150 A CN 201010232150A CN 102018760 A CN102018760 A CN 102018760A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- effect
- prostatic hyperplasia
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating benign prostatic hyperplasia, belonging to the field of traditional Chinese medicine for treating urinary system diseases and aiming to achieve the purposes of good effect and quick effect. The traditional Chinese medicine is prepared from raw materials of pink herbs, Chinese angelica, lucid ganoderma, red-rooted salvia roots, pseudo-ginseng, and the like. The traditional Chinese medicine has the effects of strengthening the body resistance, tonifying qi, nourishing blood, promoting blood circulation, removing blood stasis, helping diuresis and treating stranguria and has the advantages of obvious effect, definite effect and quick effect.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of urinary system.
Background technology
The present Chinese medicine aspect that is used for the treatment of male prostatic hyperplasia, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of prostatic hyperplasia patients are because of can not get the treatment of active drug for a long time, frequent frequent micturition, urgent micturition, dysurea, unable, the urine retention of urine, urinary incontinence, protracted course of disease, symptoms such as very misery, and Chang Bingfa urine retention, hematuria, perineal position pain.Patient and family members thereof are very dissatisfied.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of prostatic hyperplasia, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, and the slower problem that takes effect is effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of prostatic hyperplasia adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Dianthi 5---12 parts of 40 parts of Radix Angelicae Sinensis 6---50 portions of Ganodermas 2---
20 parts of Radix Salviae Miltiorrhizaes 6---50 portions of Radix Notoginseng 3---
The Chinese medicine of this treatment prostatic hyperplasia is made by following method:
(1) by above-mentioned weight ratio, Herba Dianthi, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Salviae Miltiorrhizae the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; The Herba Dianthi inducing diuresis for treating stranguria syndrome is usually used in treating urinary obstruction, odynuria because of it has remarkable diuresis.All medicine compatibilities bring out the best in each other, and have the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of inducing diuresis for treating stranguria syndrome, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Dianthi 50 gram Radix Angelicae Sinensis 60 kairine sesames 20 grams
Radix Salviae Miltiorrhizae 60 gram Radix Notoginseng 30 grams
Weight in accordance with regulations, with conventional water extraction process Herba Dianthi, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae are extracted, make extractum fine powder 51 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder, make fine particle, adorn capsule No. 0, make 360 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Herba Dianthi 200 gram Radix Angelicae Sinensis 280 kairine sesames 60 grams
Radix Salviae Miltiorrhizae 280 gram Radix Notoginseng 90 grams
By above-mentioned same method, make 1350 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Herba Dianthi 400 gram Radix Angelicae Sinensis 500 kairine sesames 120 grams
Radix Salviae Miltiorrhizae 500 gram Radix Notoginseng 200 grams
By above-mentioned same method, make 2642 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
3 parts of 10 portions of Ganodermas of 8 parts of Radix Angelicae Sinensis of Herba Dianthi
5 parts of 10 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
6 parts of 25 portions of Ganodermas of 18 parts of Radix Angelicae Sinensis of Herba Dianthi
9 parts of 25 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is example with the prostatic hyperplasia, through 7 routine clinical observations.Selecting the tcm diagnosis prostatic hyperplasia is standard: male's limb is soft weak, physical weakness, and it is not smooth to urinate---and frequent micturition, urgent micturition, dysurea, urine are unable, urine retention, urine are hesitated, urine retention.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, be the male all, there is not other serious disease, the age was 49-81 years old step, 71.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are obviously alleviated; Urine retention, urine are hesitated, urine retention obviously alleviates.
2, effective: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are alleviated to some extent; Urine is hesitated, urine retention alleviates to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 3 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 4 people, effective 2 people, invalid 1 people, total effective rate 85.7%.
Claims (1)
1. Chinese medicine for the treatment of prostatic hyperplasia is characterized in that making by comprising the following traditional Chinese medicines prescription: Herba Dianthi 5---and 40 parts, Radix Angelicae Sinensis 6---50 parts, Ganoderma 2---12 parts, Radix Salviae Miltiorrhizae 6---50 parts, Radix Notoginseng 3---20 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102321507A CN102018760A (en) | 2010-07-15 | 2010-07-15 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102321507A CN102018760A (en) | 2010-07-15 | 2010-07-15 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102018760A true CN102018760A (en) | 2011-04-20 |
Family
ID=43860809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102321507A Pending CN102018760A (en) | 2010-07-15 | 2010-07-15 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102018760A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112826881A (en) * | 2021-01-29 | 2021-05-25 | 广东德鑫制药有限公司 | A pharmaceutical composition for treating prostatic hyperplasia, and its preparation method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101530515A (en) * | 2008-03-13 | 2009-09-16 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate |
-
2010
- 2010-07-15 CN CN2010102321507A patent/CN102018760A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101530515A (en) * | 2008-03-13 | 2009-09-16 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate |
Non-Patent Citations (1)
Title |
---|
王双龙: "中医药治疗前列腺炎进展", 《中医药信息》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112826881A (en) * | 2021-01-29 | 2021-05-25 | 广东德鑫制药有限公司 | A pharmaceutical composition for treating prostatic hyperplasia, and its preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101843699B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
CN102114172A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
CN102172374A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
CN102091225A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
CN101843804A (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
CN101972349A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
CN102068529A (en) | Traditional Chinese medicine for treatment of prostatic hyperplasia | |
CN102018760A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
CN101972426A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
CN101843759B (en) | Oral Chinese medicament for treating fracture | |
CN101961416A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
CN101850022B (en) | Anti-infective Chinese medicament | |
CN101843733A (en) | Chinese medicament for treating ichthyosis | |
CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
CN102018856A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
CN101991700A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
CN102018828A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
CN102114138A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
CN101972345A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
CN102018775A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
CN101991681A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
CN101843866A (en) | Chinese medicament for treating diabetic feet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110420 |